Edwards Lifesciences Net Long-Term Debt 2010-2024 | EW
Edwards Lifesciences annual/quarterly net long-term debt history and growth rate from 2010 to 2024. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
- Edwards Lifesciences net long-term debt for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- Edwards Lifesciences net long-term debt for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- Edwards Lifesciences annual net long-term debt for 2024 was $0B, a 0% decline from 2023.
- Edwards Lifesciences annual net long-term debt for 2023 was $0B, a 0% decline from 2022.
- Edwards Lifesciences annual net long-term debt for 2022 was $0B, a 100% decline from 2021.
| Edwards Lifesciences Annual Net Long-Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $N/A |
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $-2 |
| 2020 | $-1 |
| 2019 | $-10 |
| 2018 | $-437 |
| 2017 | $176 |
| 2016 | $222 |
| 2015 | $2 |
| 2014 | $-13 |
| 2013 | $410 |
| 2012 | $40 |
| 2011 | $104 |
| 2010 | $-48 |
| 2009 | $-85 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $44.378B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $184.872B | 80.97 |
| Thermo Fisher Scientific (TMO) | United States | $161.944B | 19.59 |
| Alcon (ALC) | Switzerland | $48.146B | 32.00 |
| IDEXX Laboratories (IDXX) | United States | $35.062B | 40.55 |
| DexCom (DXCM) | United States | $27.989B | 43.26 |
| IQVIA Holdings (IQV) | United States | $27.341B | 15.13 |
| Mettler-Toledo (MTD) | United States | $22.312B | 26.01 |
| STERIS (STE) | Ireland | $22.081B | 25.25 |
| Waters (WAT) | United States | $20.688B | 29.30 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.273B | 0.00 |
| Hologic (HOLX) | United States | $13.059B | 14.09 |
| Sysmex ADR (SSMXY) | Japan | $11.620B | 0.00 |
| Penumbra (PEN) | United States | $11.341B | 89.01 |
| Globus Medical (GMED) | United States | $9.871B | 22.86 |
| Masimo (MASI) | United States | $8.698B | 36.50 |
| Teleflex (TFX) | United States | $6.355B | 9.78 |
| Glaukos (GKOS) | United States | $5.380B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.407B | 23.09 |
| TransMedics (TMDX) | United States | $3.112B | 91.10 |
| PROCEPT BioRobotics (PRCT) | United States | $2.986B | 0.00 |
| Veracyte (VCYT) | United States | $2.389B | 42.96 |
| LivaNova (LIVN) | United Kingdom | $2.011B | 12.21 |
| Nihon Kohden (NHNKY) | Japan | $1.969B | 10.77 |
| Elekta AB (EKTAY) | Sweden | $1.945B | 17.48 |
| Alphatec Holdings (ATEC) | United States | $1.604B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.266B | 6.40 |
| Pulse Biosciences (PLSE) | United States | $1.145B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| Artivion (AORT) | United States | $1.011B | 94.76 |
| OPKO Health (OPK) | United States | $0.927B | 0.00 |
| AxoGen (AXGN) | United States | $0.721B | 0.00 |
| IRadimed (IRMD) | United States | $0.666B | 34.94 |
| Mesa Laboratories (MLAB) | United States | $0.626B | 13.69 |
| RxSight (RXST) | United States | $0.598B | 0.00 |
| SiBone (SIBN) | United States | $0.581B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.577B | 9.30 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.543B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.479B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.445B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.403B | 0.00 |
| NeuroPace (NPCE) | United States | $0.383B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.334B | 17.87 |
| Pacific Biosciences Of California (PACB) | United States | $0.333B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.310B | 6.58 |
| Neuronetics (STIM) | United States | $0.288B | 0.00 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| CVRx (CVRX) | United States | $0.191B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.180B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.179B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.165B | 0.00 |
| Accuray (ARAY) | United States | $0.159B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.158B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.132B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.116B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.108B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.086B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 10.75 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.055B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.038B | 0.00 | |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.20 |